Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-08-25
2009-06-09
Bernhardt, Emily (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S254050, C544S364000, C544S371000
Reexamination Certificate
active
07544686
ABSTRACT:
The present invention provides for novel piperazinylalkylpyrazole derivatives, the preparation method thereof and the selective T-type calcium channel blocking activity thereof. Particularly, it provides a piperazinylalkylpyrazole derivative as represented by the formula set forth below or its pharmaceutically acceptable salts, and its preparation method thereof.The compound of Formula 1 is a novel piperazinylalkylpyrazole derivative, which particulary has T-type Ca2+channel blocking effect and thus can be useful as a therapeutic agent for nerve and muscle pain.
REFERENCES:
patent: 5292739 (1994-03-01), Merce-Vidal et al.
patent: 0-497-659 (1992-08-01), None
patent: WO-98/49149 (1998-11-01), None
Triggle, Biochemical Pharmacology vol. 74, p. 1-9 (2007).
Pauwels, P.J. et al. (1999). “CA++and NA++Channels Involved in Neuronal Cell Death. Protection by Flunarizine,”Life Sciences.48:1881-1893.
Richard, S. et al. (1991). “Inhibition of T-type Calcium Currents by Dihydropyridines in Mouse Embryonic Dorsal Root Ganglion Neurons,”Neuroscience. Letters132(2):229-234.
Jung, H. K. et al. (2004). “Synthesis and Biological Evaluation of Novel T-type Ca2+Channel Blockers,”Bioorganic&Medicinal Chemistry12:3965-3970.
Lee, Y. S. et al. (2004). “3,4-Dihydroquinazoline Derivatives as Novel Selective T-type Ca2+Channel Blockers,”Bioorganic&Medicinal Chemistry Letters14:3379-3384.
Nam, G. et al. (2005). “Arylaminomethylpyrazole Derivatives as Ca2+Channel Blockers,”Scientific Abstract presented at The 13thInternational Conference of Women Engineers and Scientists in Seoul, Korea, Aug. 26-29, 2005.
Choi In-Sung
Choi Kyung-Il
Koh Hun Yeong
Nam Ghilsoo
Pae Ae Nim
Bernhardt Emily
Darby & Darby P.C.
Korea Institute of Science and Technology
LandOfFree
Piperazinylalkylpyrazole derivatives useful as selective... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Piperazinylalkylpyrazole derivatives useful as selective..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperazinylalkylpyrazole derivatives useful as selective... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4068028